Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 846

1.

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.

Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ; ESC Scientific Document Group .

Eur Heart J. 2019 Aug 31. pii: ehz425. doi: 10.1093/eurheartj/ehz425. [Epub ahead of print] No abstract available.

PMID:
31504439
2.

Acute respiratory failure and mechanical ventilation in cardiogenic shock complicating acute myocardial infarction in the USA, 2000-2014.

Vallabhajosyula S, Kashani K, Dunlay SM, Vallabhajosyula S, Vallabhajosyula S, Sundaragiri PR, Gersh BJ, Jaffe AS, Barsness GW.

Ann Intensive Care. 2019 Aug 28;9(1):96. doi: 10.1186/s13613-019-0571-2.

PMID:
31463598
3.

An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction.

Attia ZI, Noseworthy PA, Lopez-Jimenez F, Asirvatham SJ, Deshmukh AJ, Gersh BJ, Carter RE, Yao X, Rabinstein AA, Erickson BJ, Kapa S, Friedman PA.

Lancet. 2019 Sep 7;394(10201):861-867. doi: 10.1016/S0140-6736(19)31721-0. Epub 2019 Aug 1.

PMID:
31378392
4.

On the Pearls and Perils of Sub-subspecialization.

Oren O, Gersh BJ, Bhatt DL.

Am J Med. 2019 Jul 29. pii: S0002-9343(19)30604-7. doi: 10.1016/j.amjmed.2019.06.052. [Epub ahead of print] No abstract available.

PMID:
31369725
5.

Utilization of Palliative Care for Cardiogenic Shock Complicating Acute Myocardial Infarction: A 15-Year National Perspective on Trends, Disparities, Predictors, and Outcomes.

Vallabhajosyula S, Prasad A, Dunlay SM, Murphree DH Jr, Ingram C, Mueller PS, Gersh BJ, Holmes DR Jr, Barsness GW.

J Am Heart Assoc. 2019 Aug 6;8(15):e011954. doi: 10.1161/JAHA.119.011954. Epub 2019 Jul 18.

6.

Changes in Management Following Detection of Previously Unknown Atrial Fibrillation by an Insertable Cardiac Monitor (from the REVEAL AF Study).

Verma A, Wachter R, Kowey PR, Halperin JL, Gersh BJ, Elkind MSV, Kaplon RE, Ziegler PD, Sherfesee L, Reiffel JA.

Am J Cardiol. 2019 Sep 15;124(6):864-870. doi: 10.1016/j.amjcard.2019.06.006. Epub 2019 Jun 24.

PMID:
31303247
7.

Response to: Risk stratification for stroke in atrial fibrillation: incorporating neurologists in the comprehensive management.

Killu AM, Gersh BJ.

Eur Heart J. 2019 Jul 13. pii: ehz500. doi: 10.1093/eurheartj/ehz500. [Epub ahead of print] No abstract available.

PMID:
31302678
8.

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.

Capodanno D, Huber K, Mehran R, Lip GYH, Faxon DP, Granger CB, Vranckx P, Lopes RD, Montalescot G, Cannon CP, Ten Berg J, Gersh BJ, Bhatt DL, Angiolillo DJ.

J Am Coll Cardiol. 2019 Jul 9;74(1):83-99. doi: 10.1016/j.jacc.2019.05.016. Review.

PMID:
31272556
9.

Sex disparities in acute kidney injury complicating acute myocardial infarction with cardiogenic shock.

Vallabhajosyula S, Ya'Qoub L, Dunlay SM, Vallabhajosyula S, Vallabhajosyula S, Sundaragiri PR, Jaffe AS, Gersh BJ, Kashani K.

ESC Heart Fail. 2019 Aug;6(4):874-877. doi: 10.1002/ehf2.12482. Epub 2019 Jul 4.

10.

Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.

Pokorney SD, Holmes DN, Thomas L, Fonarow GC, Kowey PR, Reiffel JA, Singer DE, Freeman JV, Gersh BJ, Mahaffey KW, Hylek EM, Naccarelli GV, Ezekowitz MD, Piccini JP, Peterson ED; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators.

JAMA Cardiol. 2019 Jul 3. doi: 10.1001/jamacardio.2019.1960. [Epub ahead of print]

11.

Novel approaches to the management of chronic systolic heart failure: future directions and unanswered questions.

Reddy YNV, Borlaug BA, O'Connor CM, Gersh BJ.

Eur Heart J. 2019 Jun 14. pii: ehz364. doi: 10.1093/eurheartj/ehz364. [Epub ahead of print]

PMID:
31199474
12.

Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction.

Tseng AS, Kunze KL, Lee JZ, Amin M, Neville MR, Almader-Douglas D, Killu AM, Madhavan M, Cha YM, Asirvatham SJ, Friedman PA, Gersh BJ, Mulpuru SK.

Circ Arrhythm Electrophysiol. 2019 Jun;12(6):e006951. doi: 10.1161/CIRCEP.118.006951. Epub 2019 Jun 4.

PMID:
31159582
13.

Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II.

Inohara T, Shrader P, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Go AS, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP; ORBIT AF Patients and Investigators.

Am Heart J. 2019 Jul;213:81-90. doi: 10.1016/j.ahj.2019.04.007. Epub 2019 Apr 24.

PMID:
31129441
14.

Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score.

Holmes DN, Piccini JP, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, O'Brien EC, Reiffel JA, Naccarelli GV, Ezekowitz MD, Chan PS, Singer DE, Spertus JA, Peterson ED, Thomas L.

Circ Cardiovasc Qual Outcomes. 2019 May;12(5):e005358. doi: 10.1161/CIRCOUTCOMES.118.005358.

PMID:
31092022
15.

Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry.

Perino AC, Shrader P, Turakhia MP, Ansell JE, Gersh BJ, Fonarow GC, Go AS, Kaiser DW, Hylek EM, Kowey PR, Singer DE, Thomas L, Steinberg BA, Peterson ED, Piccini JP, Mahaffey KW.

J Am Heart Assoc. 2019 May 7;8(9):e011205. doi: 10.1161/JAHA.118.011205.

16.

Acute Noncardiac Organ Failure in Acute Myocardial Infarction With Cardiogenic Shock.

Vallabhajosyula S, Dunlay SM, Prasad A, Kashani K, Sakhuja A, Gersh BJ, Jaffe AS, Holmes DR Jr, Barsness GW.

J Am Coll Cardiol. 2019 Apr 16;73(14):1781-1791. doi: 10.1016/j.jacc.2019.01.053.

PMID:
30975295
17.

International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin.

Guimarães PO, Lopes RD, Alexander JH, Thomas L, Hellkamp AS, Hijazi Z, Hylek EM, Gersh BJ, Garcia DA, Verheugt FWA, Hanna M, Flaker G, Vinereanu D, Granger CB.

J Thromb Thrombolysis. 2019 Jul;48(1):27-34. doi: 10.1007/s11239-019-01858-1.

PMID:
30972712
18.

Cardiac magnetic resonance in patients with elevated troponin and normal coronary angiography.

Bhatia S, Anstine C, Jaffe AS, Gersh BJ, Chandrasekaran K, Foley TA, Hodge D, Anavekar NS.

Heart. 2019 Aug;105(16):1231-1236. doi: 10.1136/heartjnl-2018-314631. Epub 2019 Apr 4.

PMID:
30948519
19.

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial.

Guimarães PO, Pokorney SD, Lopes RD, Wojdyla DM, Gersh BJ, Giczewska A, Carnicelli A, Lewis BS, Hanna M, Wallentin L, Vinereanu D, Alexander JH, Granger CB.

Clin Cardiol. 2019 May;42(5):568-571. doi: 10.1002/clc.23178. Epub 2019 Apr 9.

20.

Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation.

Madhavan M, Holmes DN, Piccini JP, Ansell JE, Fonarow GC, Hylek EM, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Chan P, Allen LA, Gersh BJ; ORBIT AF Investigators.

Am Heart J. 2019 May;211:77-89. doi: 10.1016/j.ahj.2019.01.005. Epub 2019 Jan 30.

PMID:
30901602
21.

Atrial fibrillation ablation in practice: assessing CABANA generalizability.

Noseworthy PA, Gersh BJ, Kent DM, Piccini JP, Packer DL, Shah ND, Yao X.

Eur Heart J. 2019 Apr 21;40(16):1257-1264. doi: 10.1093/eurheartj/ehz085.

PMID:
30875424
22.

Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry).

Vemulapalli S, Inohara T, Kim S, Thomas L, Piccini JP, Patel MR, Chang P, Fonarow GC, Ezekowitz MD, Hylek E, Go AS, Kowey PR, Mahaffey KW, Gersh BJ, Peterson ED.

Am J Cardiol. 2019 May 15;123(10):1628-1636. doi: 10.1016/j.amjcard.2019.02.010. Epub 2019 Feb 23.

PMID:
30846214
23.

Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial.

Washam JB, Hohnloser SH, Lopes RD, Wojdyla DM, Vinereanu D, Alexander JH, Gersh BJ, Hanna M, Horowitz J, Hylek EM, Xavier D, Verheugt FWA, Wallentin L, Granger CB; ARISTOTLE Committees and Investigators.

J Thromb Thrombolysis. 2019 Apr;47(3):345-352. doi: 10.1007/s11239-019-01823-y.

PMID:
30790160
24.

Stroke prevention in atrial fibrillation: Closing the gap.

Pokorney SD, Gersh BJ, Ahmad A, Al-Khatib SM, Blank M, Coylewright M, DiBattiste P, Healey JS, Hedrich O, Hylek EM, Kline-Rogers E, Peterson ED, Mendys P, Mirro MJ, Naccarelli G, Patel P, Ruff CT, Rutman H, Stockbridge N, Temple R, Granger CB.

Am Heart J. 2019 Apr;210:29-38. doi: 10.1016/j.ahj.2018.10.004. Epub 2018 Oct 25. No abstract available.

PMID:
30731371
25.

Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial.

Huang X, Redfors B, Chen S, Gersh BJ, Mehran R, Zhang Y, McAndrew T, Ben-Yehuda O, Mintz GS, Stone GW.

Catheter Cardiovasc Interv. 2019 Aug 1;94(2):172-180. doi: 10.1002/ccd.28096. Epub 2019 Jan 28.

PMID:
30690854
26.

Generalizability of the FOURIER trial to routine clinical care: Do trial participants represent patients in everyday practice?

Yao X, Gersh BJ, Lopez-Jimenez F, Shah ND, Noseworthy PA.

Am Heart J. 2019 Mar;209:54-62. doi: 10.1016/j.ahj.2018.09.015. Epub 2018 Dec 16.

PMID:
30685675
27.

Modern Management of ST-Segment Elevation Myocardial Infarction.

Frampton J, Devries JT, Welch TD, Gersh BJ.

Curr Probl Cardiol. 2018 Sep 14. pii: S0146-2806(18)30130-0. doi: 10.1016/j.cpcardiol.2018.08.005. [Epub ahead of print] Review.

PMID:
30660333
28.

The hypertrophic cardiomyopathy paradox: better with age.

Geske JB, Gersh BJ.

Eur Heart J. 2019 Mar 21;40(12):994-996. doi: 10.1093/eurheartj/ehy889. No abstract available.

PMID:
30629161
29.

Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.

Diamond J, Madhavan MV, Sabik JF 3rd, Serruys PW, Kappetein AP, Leon MB, Taggart DP, Berland J, Morice MC, Gersh BJ, Kandzari DE, Dressler O, Stone GW.

JACC Cardiovasc Interv. 2018 Dec 24;11(24):2441-2450. doi: 10.1016/j.jcin.2018.09.008.

PMID:
30573053
30.

Temporary Mechanical Circulatory Support for Refractory Cardiogenic Shock Before Left Ventricular Assist Device Surgery.

Vallabhajosyula S, Arora S, Lahewala S, Kumar V, Shantha GPS, Jentzer JC, Stulak JM, Gersh BJ, Gulati R, Rihal CS, Prasad A, Deshmukh AJ.

J Am Heart Assoc. 2018 Nov 20;7(22):e010193. doi: 10.1161/JAHA.118.010193.

31.

Risk stratification for stroke in atrial fibrillation: a critique.

Killu AM, Granger CB, Gersh BJ.

Eur Heart J. 2019 Apr 21;40(16):1294-1302. doi: 10.1093/eurheartj/ehy731.

PMID:
30508086
32.

Trends, Predictors, and Outcomes of Temporary Mechanical Circulatory Support for Postcardiac Surgery Cardiogenic Shock.

Vallabhajosyula S, Arora S, Sakhuja A, Lahewala S, Kumar V, Shantha GPS, Egbe AC, Stulak JM, Gersh BJ, Gulati R, Rihal CS, Prasad A, Deshmukh AJ.

Am J Cardiol. 2019 Feb 1;123(3):489-497. doi: 10.1016/j.amjcard.2018.10.029. Epub 2018 Nov 6.

PMID:
30473325
33.

In Reply-Efficacy of Warfarin Anticoagulation and Incident Dementia: Does Cognitive Impairment Reduce Efficacy?

Madhavan M, Gersh BJ, Weston SA, Chamberlain AM.

Mayo Clin Proc. 2018 Nov;93(11):1687-1688. doi: 10.1016/j.mayocp.2018.08.018. No abstract available.

PMID:
30392552
34.

Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.

Washam JB, Holmes DN, Thomas LE, Pokorney SD, Hylek EM, Fonarow GC, Mahaffey KW, Gersh BJ, Kowey PR, Ansell JE, Go AS, Reiffel JA, Freeman JV, Singer DE, Naccarelli G, Blanco R, Peterson ED, Piccini JP.

J Am Heart Assoc. 2018 Sep 18;7(18):e008928. doi: 10.1161/JAHA.118.008928.

35.

Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA2DS2-VASc Scores: Findings From the ORBIT-AF I and II Registries.

Jackson LR 2nd, Kim S, Fonarow GC, Freeman JV, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Singer D, Thomas L, Blanco R, Peterson ED, Piccini JP Sr; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation Patients and Investigators.

J Am Heart Assoc. 2018 Aug 21;7(16):e008764. doi: 10.1161/JAHA.118.008764.

36.

Early Natural History of Spontaneous Coronary Artery Dissection.

Waterbury TM, Tweet MS, Hayes SN, Eleid MF, Bell MR, Lerman A, Singh M, Best PJM, Lewis BR, Rihal CS, Gersh BJ, Gulati R.

Circ Cardiovasc Interv. 2018 Sep;11(9):e006772. doi: 10.1161/CIRCINTERVENTIONS.118.006772.

PMID:
30354594
37.

Concomitant Intra-Aortic Balloon Pump Use in Cardiogenic Shock Requiring Veno-Arterial Extracorporeal Membrane Oxygenation.

Vallabhajosyula S, O'Horo JC, Antharam P, Ananthaneni S, Vallabhajosyula S, Stulak JM, Eleid MF, Dunlay SM, Gersh BJ, Rihal CS, Barsness GW.

Circ Cardiovasc Interv. 2018 Sep;11(9):e006930. doi: 10.1161/CIRCINTERVENTIONS.118.006930.

PMID:
30354593
38.

Reappraisal of Ischemic Heart Disease.

Kaski JC, Crea F, Gersh BJ, Camici PG.

Circulation. 2018 Oct 2;138(14):1463-1480. doi: 10.1161/CIRCULATIONAHA.118.031373.

PMID:
30354347
39.

Risk of Appropriate Therapy and Death Before Therapy After Implantable Cardioverter-Defibrillator Generator Replacement.

Witt CM, Waks JW, Mehta RA, Friedman PA, Kramer DB, Buxton AE, Mulpuru SK, Noseworthy PA, Hodge DO, Lushinsky EC, Mulholland MB, Cha YM, Gersh BJ, Madhavan M.

Circ Arrhythm Electrophysiol. 2018 Aug;11(8):e006155. doi: 10.1161/CIRCEP.117.006155.

PMID:
30354311
40.

Ten-Year Follow-Up of Off-Pump and On-Pump Multivessel Coronary Artery Bypass Grafting: MASS III.

Hueb W, Rezende PC, Gersh BJ, Soares PR, Favarato D, Lima EG, Garzillo CL, Jatene FB, Ramires JAF, Filho RK.

Angiology. 2019 Apr;70(4):337-344. doi: 10.1177/0003319718804402. Epub 2018 Oct 4.

PMID:
30286625
41.

Cognitive dysfunction in atrial fibrillation.

Madhavan M, Graff-Radford J, Piccini JP, Gersh BJ.

Nat Rev Cardiol. 2018 Dec;15(12):744-756. doi: 10.1038/s41569-018-0075-z. Review.

PMID:
30275499
42.

Delays in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients Presenting With Cardiogenic Shock.

Kochar A, Al-Khalidi HR, Hansen SM, Shavadia JS, Roettig ML, Fordyce CB, Doerfler S, Gersh BJ, Henry TD, Berger PB, Jollis JG, Granger CB.

JACC Cardiovasc Interv. 2018 Sep 24;11(18):1824-1833. doi: 10.1016/j.jcin.2018.06.030.

PMID:
30236355
43.

B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation.

Inohara T, Kim S, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP; ORBIT AF Patients and Investigators.

Heart. 2018 Sep 18. pii: heartjnl-2018-313642. doi: 10.1136/heartjnl-2018-313642. [Epub ahead of print]

PMID:
30228248
44.

Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry).

Thind M, Holmes DN, Badri M, Pieper KS, Singh A, Blanco RG, Steinberg BA, Fonarow GC, Gersh BJ, Mahaffey KW, Peterson ED, Reiffel JA, Piccini JP, Kowey PR; ORBIT-AF Investigators and Patients.

Am J Cardiol. 2018 Nov 15;122(10):1677-1683. doi: 10.1016/j.amjcard.2018.07.045. Epub 2018 Aug 20.

PMID:
30227964
45.

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation.

Christersson C, Wallentin L, Andersson U, Alexander JH, Alings M, De Caterina R, Gersh BJ, Granger CB, Halvorsen S, Hanna M, Huber K, Hylek EM, Lopes RD, Oh BH, Siegbahn A.

Heart. 2019 Feb;105(3):235-242. doi: 10.1136/heartjnl-2018-313351. Epub 2018 Sep 12.

46.

Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.

Jackson LR 2nd, Kim S, Shrader P, Blanco R, Thomas L, Ezekowitz MD, Ansell J, Fonarow GC, Gersh BJ, Go AS, Kowey PR, Mahaffey KW, Hylek EM, Peterson ED, Piccini JP Sr.

J Thromb Thrombolysis. 2018 Nov;46(4):435-439. doi: 10.1007/s11239-018-1715-1.

47.

Remote ischaemic conditioning for myocardial infarction or elective PCI: systematic review and meta-analyses of randomised trials.

Haller PM, Vargas KG, Haller MC, Piackova E, Wojta J, Gyöngyösi M, Gersh BJ, Kiss A, Podesser BK, Huber K.

Eur Heart J Acute Cardiovasc Care. 2018 Jun 1:2048872618784150. doi: 10.1177/2048872618784150. [Epub ahead of print]

PMID:
29911392
48.

Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT-AF.

O'Brien EC, Holmes DN, Thomas L, Fonarow GC, Kowey PR, Ansell JE, Mahaffey KW, Gersh BJ, Peterson ED, Piccini JP, Hylek EM.

J Am Heart Assoc. 2018 Jun 9;7(12). pii: e006391. doi: 10.1161/JAHA.117.006391.

49.

Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery.

Yao X, Gersh BJ, Holmes DR Jr, Melduni RM, Johnsrud DO, Sangaralingham LR, Shah ND, Noseworthy PA.

JAMA. 2018 May 22;319(20):2116-2126. doi: 10.1001/jama.2018.6024.

50.

Risk of cardiovascular events and incident atrial fibrillation in patients without prior atrial fibrillation: Implications for expanding the indications for anticoagulation.

Yao X, Gersh BJ, Sangaralingham LR, Shah ND, Noseworthy PA.

Am Heart J. 2018 May;199:137-143. doi: 10.1016/j.ahj.2018.02.005. Epub 2018 Feb 10.

PMID:
29754652

Supplemental Content

Loading ...
Support Center